In HFD-fed mice, supplementation with cheonggukjang (a short-ripened fermented soybean paste) led to significantly lower fasting glucose and insulin than HFD controls and improved hepatic steatosis, indicating anti-obesogenic effects that extend to glycemic endpoints [174]. This evidence concerns the gene INS and fatty liver disease.